Ascentage Pharma (AAPG) Secures Key Drug Listings in China's 2026 NRDL, Expanding Market Access

· gurufocus.com

On November 15, 2026, Ascentage Pharma Group International (AAPG) announced the inclusion of two of its major therapies in China's 2026 National Reimbursement D

On November 15, 2026, Ascentage Pharma Group International AAPG announced the inclusion of two of its major therapies in China’s 2026 National Reimbursement D...


More AI market news · Market heatmap · StrategyVerse · Quant Research · WOBR.AI